Results 211 to 220 of about 506,874 (259)
Some of the next articles are maybe not open access.
Dihydrochalcones as Antitumor Agents
Current Medicinal Chemistry, 2022Abstract: Dihydrochalcones are a class of secondary metabolites, possessing several biological properties such as antitumor, antioxidant, antibacterial, antidiabetic, estrogenic, anti-inflammatory, antithrombotic, antiviral, neuroprotective, and immunomodulatory properties; therefore, they are currently considered promising candidates in the drug ...
Fabiola De Luca +3 more
openaire +2 more sources
Anti-Cancer Agents in Medicinal Chemistry, 2007
Natural and synthetic carbazoles, either in a pure substituted or in an annellated substituted form, represent an important and heterogeneous class of anticancer agents, which has grown considerably over the last two decades. Many carbazole derivatives have been tested for cyctotoxic activity, some of them have entered clinical trials, but only ...
Asche, Christian, Demeunynck, Martine
openaire +2 more sources
Natural and synthetic carbazoles, either in a pure substituted or in an annellated substituted form, represent an important and heterogeneous class of anticancer agents, which has grown considerably over the last two decades. Many carbazole derivatives have been tested for cyctotoxic activity, some of them have entered clinical trials, but only ...
Asche, Christian, Demeunynck, Martine
openaire +2 more sources
Mini-Reviews in Medicinal Chemistry, 2004
Most anticancer titanium compounds act against tumors in the gastrointestinal tract. Activity towards breast, lung and skin (melanoma) cancers is shown by some as well. Among their appealing properties is that they do not show common side effects of widely used cytostatic agents such as emesis, alopecia or bone marrow impairment.
Caruso Francesco, Rossi Miriam
openaire +5 more sources
Most anticancer titanium compounds act against tumors in the gastrointestinal tract. Activity towards breast, lung and skin (melanoma) cancers is shown by some as well. Among their appealing properties is that they do not show common side effects of widely used cytostatic agents such as emesis, alopecia or bone marrow impairment.
Caruso Francesco, Rossi Miriam
openaire +5 more sources
Bortezomib as an Antitumor Agent
Current Pharmaceutical Biotechnology, 2006The ubiquitin-proteasome pathway (UPP) is the major non-lysosomal proteolytic system in the cytosol and nucleus of all eukaryotic cells. Bortezomib (also known as PS-341 and Velcade) is a proteasome inhibitor, a novel class of cancer therapies. Bortezomib blocks multi-ubiquitinated protein degradation by inhibiting 26S proteasome activity, including ...
ROCCARO A. M +7 more
openaire +4 more sources
Journal of Drug Targeting, 1996
To enhance the selective delivery of antitumor drugs into regional lymph nodes and cancerous tissues via a hyaluronate (HA) receptor (CD44), we synthesized HA-mitomycin C complex and HA-epirubicin complex. To investigate the specific distribution of HA into regional lymph nodes and to evaluate the HA receptor on lewis lung carcinoma cells, we also ...
Yutaka Atomi +10 more
openaire +3 more sources
To enhance the selective delivery of antitumor drugs into regional lymph nodes and cancerous tissues via a hyaluronate (HA) receptor (CD44), we synthesized HA-mitomycin C complex and HA-epirubicin complex. To investigate the specific distribution of HA into regional lymph nodes and to evaluate the HA receptor on lewis lung carcinoma cells, we also ...
Yutaka Atomi +10 more
openaire +3 more sources
Preexisting antitumor immunity augments the antitumor effects of chemotherapy
Cancer Immunology, Immunotherapy, 2013Efficacy of cancer chemotherapy is generally believed to be the result of direct drug killing of tumor cells. However, increased tumor cell killing does not always lead to improved efficacy. Herein, we demonstrate that the status of antitumor immunity at the time of chemotherapy treatment is a critical factor affecting the therapeutic outcome in that ...
Kangla Tsung +4 more
openaire +2 more sources
Antitumor Effects of Interferon
Acta Oncologica, 1973Both natural and recombinant interferons have shown definite antitumor activity in some patients with some malignancies. The history of the development of interferon as an antitumor agent is reviewed, with special attention to its use in mice bearing 'spontaneously' appearing tumors and in mice injected with tumorigenic viruses or transplantable tumor ...
openaire +5 more sources
Molecular and Cellular Biochemistry, 1981
Tuftsin, a physiological tetrapeptide derived from the Fc region of leukophilic IgG possesses a variety of immunopotentiating properties including the ability to act as an immunotherapeutic agent against the experimental tumors, L1210 leukemia and Cloudman S-91 melanoma. Although the mechanism of action of tuftsin in vivo is not known, several types of
Kenji Nishioka +3 more
openaire +3 more sources
Tuftsin, a physiological tetrapeptide derived from the Fc region of leukophilic IgG possesses a variety of immunopotentiating properties including the ability to act as an immunotherapeutic agent against the experimental tumors, L1210 leukemia and Cloudman S-91 melanoma. Although the mechanism of action of tuftsin in vivo is not known, several types of
Kenji Nishioka +3 more
openaire +3 more sources
Antitumor activity of a new antitumor antibiotic, sporamycin.
Gan, 1977Sporamycin is an antitumor antibiotic isolated from the culture filtrate of Streptosporangium strain No. PO-357. Hydrolysate of the antibiotic showed at least 12 kinds of amino acid, and the molecular weight was calculated approximately as 8,500 approximately 9,000.
Komiyama, K, Takeshima, H, Umezawa, I
openaire +3 more sources